ArticleJournal of cancer survivorship : research and practice2026
Hospitalization for medical conditions in adolescent and young adult cancer survivors: a nationwide cohort study using the Netherlands Cancer Registry.
Article in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeTo examine the long-term risk of hospitalization for medical conditions in adolescent and young adult (AYA) cancer survivors compared to a cancer-free AYA cohort.
methodsRetrospective cohort study of 42,653 ≥ 2-year cancer survivors diagnosed at ages 18-39 (1993-2016) in the Netherlands Cancer Registry, and 169,342 matched cancer-free controls (1:4 by age, sex and municipality). Hospitalizations for relevant medical conditions were identified through national hospital admission data. Survivors and controls were followed through December 2021. Hospitalization incidence rate ratios (IRRs) and cumulative incidences were calculated, with IRRs stratified by tumour type and therapy (chemotherapy, radiotherapy).
resultsAYA cancer survivors had a significantly increased IRR of hospitalization for any medical condition (adjusted IRR 1.73; 95% CI 1.64 to 1.82), as well as for most individual conditions. The cumulative incidence of hospitalization for any medical condition was 25.4% at 25 years post-index, with most individual conditions below 5%. Most tumour subgroups had significantly increased IRRs compared to controls, with the highest IRRs observed for Hodgkin lymphoma and leukaemia. In general, elevated IRRs were more pronounced among survivors who received chemotherapy or radiotherapy.
conclusionsAYA cancer survivors have an increased risk of hospitalization for most medical conditions compared to AYAs without a cancer history, though absolute long-term risk is low. As hospital admissions reflect only part of the clinical and societal burden, the findings may underestimate the total impact of late effects. IMPLICATIONS FOR CANCER SURVIVORS: AYA cancer survivors may benefit from long-term, risk-based survivorship care focused on early detection and management of late effects, especially after chemotherapy and radiotherapy.
Indexed as
Identifiers
41793643What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.